XFACTOR 2022, L.P. joins Boobybiome Ltd cap table as new shareholder
Published
XFACTOR 2022, L.P. has joined the Boobybiome Ltd cap table as a new shareholder, according to the company's latest confirmation statement for the period ending 30 June 2026. The investor now holds 12,604 Ordinary shares in the business.
Boobybiome Ltd is a London-based biotechnology firm founded in 2019. The company develops microbiome products derived from breast milk research to improve infant gut health, providing science-driven solutions for babies and parents.
The new entrant joins several existing institutional shareholders. Venrex Nominees Limited remains the largest holder with 165,100 shares, followed by Cade Hill Investments Limited with 157,120 shares. Other shareholders on the cap table include SFC Nominees Limited with 33,978 shares and Discovery Park Ventures Limited with 33,020 shares.
The filing also confirms the continued holdings of Empirical Ventures BBI Nominees Limited with 31,204 shares, Kayan Ventures Fund I LP with 21,483 shares, and Evenlode Impact Limited with 16,810 shares. No shareholders exited the cap table during this reporting period.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | XFACTOR 2022, L.P. | 12,604 | — | ORDINARY 12,604 |
Current shareholders (9)
| Shareholder | Total shares | Share classes |
|---|---|---|
| CADE HILL INVESTMENTS LIMITED | 157,120 | ORDINARY 157,120 |
| VENREX NOMINEES LIMITED - VENREX LP | 86,790 | ORDINARY 86,790 |
| VENREX NOMINEES LIMITED - VENREX X | 78,310 | ORDINARY 78,310 |
| SFC NOMINEES LIMITED | 33,978 | ORDINARY 33,978 |
| DISCOVERY PARK VENTURES LIMITED | 33,020 | ORDINARY 33,020 |
| EMPIRICAL VENTURES BBI NOMINEES LIMITED | 31,204 | ORDINARY 31,204 |
| KAYAN VENTURES FUND I LP | 21,483 | ORDINARY 21,483 |
| EVENLODE IMPACT LIMITED | 16,810 | ORDINARY 16,810 |
| XFACTOR 2022, L.P. | 12,604 | ORDINARY 12,604 |
Contact the editorial team at [email protected]